Fat Away Pen – AOD-9604 10mg

The Fat Away Pen contains 10 mg of AOD-9604 in a convenient 2.6 mL pre-filled peptide pen. With 240 precision clicks, the multi-dose format is designed for research involving AOD-9604 and pathways associated with lipolysis, fat metabolism, energy utilisation and body composition.

Each pen is supplied with 6 sterile needles.

Key Features

• 10 mg AOD-9604 per pen
• 2.6 mL pre-filled peptide pen
• 240 precision clicks
• Approximately 41.7 mcg AOD-9604 per click
• 6 clicks ≈ 250 mcg
• 12 clicks ≈ 500 mcg
• Supplied with 6 sterile needles
• Research interest in lipid metabolism and lipolysis
• Convenient multi-dose format
• Precision MSSPT peptide pen technology

About AOD-9604

AOD-9604 is a synthetic peptide fragment derived from the C-terminal region of human growth hormone and has been investigated for its potential effects on fat metabolism and lipid pathways.

Research into AOD-9604 has focused on mechanisms including lipolysis, inhibition of lipogenesis and fatty-acid metabolism. It has attracted particular interest in research relating to body composition, metabolic pathways and energy utilisation.

AOD-9604 is distinct from full-length growth hormone and has been investigated for its metabolic effects without being designed to replicate the complete hormonal activity of growth hormone.

Research Areas

AOD-9604 research has explored its potential relationship with:

• Lipolysis and fat metabolism
• Fatty-acid utilisation
• Lipogenesis pathways
• Energy metabolism
• Body-composition research
• Metabolic health
• Preservation of lean tissue during caloric restriction

These are areas of research interest and should not be interpreted as established medical benefits or claims of weight-loss treatment.

Research Dosage Protocol

The following information is the manufacturer-supplied research protocol and is provided for research reference only. It is not a recommendation or instruction for human use.

Standard research dose:

• 250–500 mcg per administration
• 250 mcg: approximately 6 clicks
• 500 mcg: approximately 12 clicks

Frequency described in the supplied protocol:

• Once daily
• Alternatively, 5–6 days per week with 1–2 days off for maintenance research protocols

Timing: The supplied protocol specifies morning administration, with administration on an empty stomach.

Research cycle: 8–12 weeks, with extended research protocols of 12–16 weeks described, followed by approximately 4–6 weeks off.

Click conversion: approximately 41.7 mcg AOD-9604 per click.

Precision Peptide Pen Technology

The Fat Away Pen incorporates MSSPT (Molecular Stabilisation and Storage Protection Technology), designed to support formulation stability against environmental factors including light, oxygen, moisture and temperature fluctuations.

The pre-filled format provides convenient click-based measurement without conventional reconstitution.

Storage & Handling

• Store according to the manufacturer’s recommended storage conditions.
• Refrigerate where specified and never freeze.
• If stored outside refrigeration, keep in a cool, dry environment within the recommended temperature range.
• Keep the pen capped and protected from direct light and excessive heat.
• Keep out of reach of children.
• Do not use if the solution is cloudy, discoloured or contains visible particles.
• Discard expired or visibly compromised product appropriately.

Research & Safety Information

Fat Away Pen is supplied by Lekker Peptides for research purposes only. AOD-9604 is an investigational peptide and should not be represented as an approved treatment for obesity, weight loss or metabolic disease.

The product is not intended to diagnose, treat, cure or prevent any disease. Statements have not been evaluated or approved by SAHPRA, the FDA or other regulatory authorities for the uses described above.

Research involving AOD-9604 should be conducted with appropriate professional oversight.

For research use only. Not for human consumption.